Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Rivaroxaban × Plasma cell × Clear all

Phase

Status

Unknown 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Classical hematology 2 Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Plasma cell 1 Genitourinary 1 CNS 1 Breast 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 67 Cyclophosphamide 44 Bortezomib 39 Lenalidomide 23 Melphalan 22 Thalidomide 19 pomalidomide 16 fludarabine 13 daratumumab 13 carfilzomib 9 Doxorubicin 8 Filgrastim 7 Busulfan 6 Prednisone 5 Peripheral Blood Stem Cell Transplantation 5 Calcium Dobesilate 5 Bendamustine Hydrochloride 5 selinexor 4 sargramostim 4 ixazomib 4 isatuximab 4 fludarabine phosphate 4 Surveys and Questionnaires 4 Mycophenolic Acid 4 Etoposide 4 Clarithromycin 4 liposomal doxorubicin 3 dexamethasone acetate 3 Radiotherapy 3 Neoadjuvant Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03428373 2024-02-29

RithMM

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2/3 Unknown

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡